Heart News and Research

RSS

Drug developed at Duke is approved by FDA as only therapy for congenital athymia

The phone rang into the pediatric unit that Louise Markert, M.D., Ph.D., was staffing as a junior faculty member in 1991. Had she not answered, there would have been little hope for the more than one hundred patients who were subsequently treated.

11 Oct 2021

Common oral diuretic pill may be a potential candidate for Alzheimer's treatment

A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration may be a potential candidate for an Alzheimer's disease treatment for those who are at genetic risk, according to findings published in Nature Aging.

11 Oct 2021

New machine-learning model can identify individuals at risk of rare cardiomyopathy

A machine-learning model can identify patients at risk of a rare cardiomyopathy, according to a study published in Nature Communications.

11 Oct 2021

Formal health care transition programs needed to provide uninterrupted support for youth with Kawasaki disease

Kawasaki disease is the most common cause of acquired heart disease that develops in early childhood, creating inflammation in blood vessels, particularly heart arteries.

11 Oct 2021

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

Researchers have investigated the differences between 'classic' myocarditis, COVID-19 induced myocarditis, and vaccine-related myocarditis.

11 Oct 2021

Sero-epidemiological insights into pathways to COVID-19 immunity

A new study posted to the medRxiv* server attempts to utilize serology as a tool to identify disparities in infection rates and vaccination coverage.

10 Oct 2021

Myocarditis after mRNA COVID vaccine extremely rare, most cases mild or moderate

The estimated incidence of myocarditis among patients that have received at least one dose of the Pfizer-BioNTech (BNT162b2) mRNA vaccine against coronavirus disease 2019 (COVID-19) was 2.13 cases per 100,000 persons, primarily affecting young men and presenting mostly as mild or moderate illness, as demonstrated by a recent study published in the New England Journal of Medicine.

10 Oct 2021

COVID-19 vaccination rates among minority populations

A new study discusses offers insights into how minority groups can be effectively persuaded to take the currently available COVID-19 vaccines.

10 Oct 2021

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Hospital admissions and deaths due to COVID-19 were drastically reduced at two weeks or more from the first dose of either the Pfizer or AstraZeneca vaccine.

10 Oct 2021

New digital program to improve physical and mental wellbeing of young cancer survivors

A digital program enhancing physical and mental wellbeing for young people adjusting to life after cancer, will be developed by The University of Queensland in partnership with cancer support organisation Canteen.

8 Oct 2021

Study uncovers toxic air pollutant mixtures linked to poor childhood asthma outcomes

Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel machine learning algorithm and used it to identify previously unknown mixtures of toxic air pollutants that appear to be linked to poor asthma outcomes later in a child's life.

8 Oct 2021

Study explores the relationship between cytokines in saliva and COVID-19 severity

Penn State College of Medicine researchers are involved in an ongoing study looking at the relationship between proteins called cytokines in saliva and COVID-19 infection to help predict the severity of infection.

8 Oct 2021

Study aims to find ways of identifying children at risk for severe COVID-19

An ongoing study is looking at the relationship between cytokines in saliva and COVID-19 infection to help predict the severity of infection.

8 Oct 2021

Characterization of circulating neutrophils from hospitalized COVID-19 patients

A new preprint deals with the characterization of neutrophil phenotypes in an attempt to provide biomarkers that can predict severe disease in patients hospitalized with COVID-19.

8 Oct 2021

Organ centers to transplant patients: Get a covid shot or move down on waitlist

A Colorado kidney transplant candidate who was bumped to inactive status for failing to get a covid-19 vaccine has become the most public example of an argument roiling the nation's more than 250 organ transplant centers.

8 Oct 2021

Study reveals the trends in recreational ketamine use and availability in the U.S.

Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.

7 Oct 2021

Study uncovers new drug target for myelodysplastic syndrome

Mount Sinai and UC San Diego researchers have shown for the first time how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies and solid tumors, according to a study published in Cancer Discovery in October.

7 Oct 2021

Additional health care support needed to improve medication adherence among people with hypertension

People with hypertension, or high blood pressure, play a key role in whether they use medication appropriately to manage their blood pressure.

7 Oct 2021

Ear sensors help increase safety for SARS-CoV-2 patients in home isolation

Using telemedicine, COVID-19 patients can be cared for safely at home – from initial home isolation to recovery or, in case problems arise, admission to hospital.

7 Oct 2021

Existing drug reduces obesity and fatty liver in mice without changes in food intake or daily activity

Researchers at Johns Hopkins Medicine have found that a drug first developed to treat Alzheimer's disease, schizophrenia and sickle cell disease reduces obesity and fatty liver in mice and improves their heart function — without changes in food intake or daily activity.

7 Oct 2021

Heart News and Research

Drug developed at Duke is approved by FDA as only therapy for congenital athymia

Common oral diuretic pill may be a potential candidate for Alzheimer's treatment

New machine-learning model can identify individuals at risk of rare cardiomyopathy

Formal health care transition programs needed to provide uninterrupted support for youth with Kawasaki disease

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

Sero-epidemiological insights into pathways to COVID-19 immunity

Myocarditis after mRNA COVID vaccine extremely rare, most cases mild or moderate

COVID-19 vaccination rates among minority populations

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

New digital program to improve physical and mental wellbeing of young cancer survivors

Study uncovers toxic air pollutant mixtures linked to poor childhood asthma outcomes

Study explores the relationship between cytokines in saliva and COVID-19 severity

Study aims to find ways of identifying children at risk for severe COVID-19

Characterization of circulating neutrophils from hospitalized COVID-19 patients

Organ centers to transplant patients: Get a covid shot or move down on waitlist

Study reveals the trends in recreational ketamine use and availability in the U.S.

Study uncovers new drug target for myelodysplastic syndrome

Additional health care support needed to improve medication adherence among people with hypertension

Ear sensors help increase safety for SARS-CoV-2 patients in home isolation

Existing drug reduces obesity and fatty liver in mice without changes in food intake or daily activity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News